Opening hours administrative offices
9:00 a.m. - 4:00 p.m.
How to reach us
Appointment: (514) 340 8222 x 23114-1
Surgery: (514) 340 8222 x 23114-4
Where to find us
Pavilion E, 7th floor
Daily surgical and medical gyn-oncology clinics
Cancer Genetic screening and prevention
Clinical research studies (Clinical Trials)
ERAS program (patient education animations)
Gyn-Onc health Information Service
The Gynecologic Oncology program at the Segal Cancer Centre was established to concentrate exclusively on the study and treatment of gynecologic cancers, integrating prevention strategies, screening tools, detection methods, sophisticated diagnostic equipment, skillful pelvic and abdominal surgery, innovative chemotherapy/immunotherapy/targeted therapy protocols, hi-tech radiation therapy and best supportive care practices. Treatment of patients presenting with cancer of the vulva, vagina, cervix, uterus, fallopian tubes, ovaries, pelvis or peritoneum is being centralized by the team of gynecologic oncologists whose interdisciplinary approach allows for efficient and optimal patient care without the need for unnecessary and redundant examinations.
The program integrates the use of Colposcopy in screening for gynecologic abnormalities and cancers, as well as the use of cytology and pathology in screening and detecting anomalies of the lower genital tract. Patients are provided with in-depth information about Human Papilloma Virus (HPV) infections and its role in the development of pre-cancer and cancer. This clinic is also an essential setting to the promotion of the HPV vaccine among women.
Daily surgical and medical clinics are held at the Gynecologic Oncology program to screen, detect, diagnose, follow, and treat women with gynecologic cancer, where patients are assessed for surgery, medical therapy which includes chemotherapy, immunotherapy, targeted therapy, and supportive care. Weekly tumour board conferences are held where the team members bring their unique perspectives and expertise to the discussion of individual cancer cases in order to elaborate the best treatment options available.
Since December 2007, the Gynecologic Oncology team has pioneered the introduction of computer assisted “Robotic” surgery in the surgical arsenal for gynecologic cancers, and has become a leader in the use of this minimal invasive technology in Canada. Patients’ progress deems promising and improved as compared to the standard surgical procedures. We have shown that hospitalization and recovery time have been significantly shortened, wound healing being remarkably improved given the reduced surgical invasion. Patients have reported a general improvement in quality of life and express an overall great satisfaction with its use.
Since 2018, ERAS-based (Enhanced Recovery After Surgery) patient education animations have been provided by the team to patients prior to surgery, to help improve preparedness and promote easier recovery.
Genetic screening, crucial to all fields of oncology, is an integral part of the Gynecologic Oncology program and this service is provided by the Cancer Genetic Screening and Prevention team in collaboration with the Pathology Department.
Clinical research studies with the most evolved protocols are available to patients. In addition, basic research is conducted on the molecular aspects of gynecologic cancer development, and the application of new treatment modalities based on genetic engineering and translational research.
Essential to the optimal management and treatment of each individual patient are the multitude of skills present in the multifaceted team of highly trained professionals working continuously together and forming the “Gynecologic Oncology Unit”.
Healthcare professionals can find the treatment algorithms.
Medical Director: Walter Gotlieb, MD, PhD
Nurse Navigator: Nancy Drummond, RN, MSc(A), CON(C)
Clinical Administrator: Lianna Mantley
Téléphone : (514) 340-8222 x 23114-4
Secretary : Ana Massa
Téléphone : (514) 340-8222 x 23114-1
|Gynecologic Oncologists||Medical Oncologist||Geneticist|
|Walter Gotlieb, MD, PhD||David Melnychuk, MD||William Foulkes, MB, PhD|
|Susie Lau, MD||Surgical Specialists||Genetic Counsellors|
|Shannon Salvador, MD||Carol Ann Vasilevsky, MD||Nora Wong, MS,CCGC|
|Ahmed Mousa, MD||Jacob Garzon, MD||Sonia Zaor, MSc, CCGC|
|Radiation Oncologists||Shannon Fraser, MD||Genetic Coordinator|
|Boris Bahoric, MD||Philip Gordon, MD||Laura Hayes|
|Tamim Niazi, MD||Franck Bladou, MD|
|Siavosh Vakilian, MD||Pathologist|
|Mark Leventhal, MD|
|Vincent Pelsser, MD|
|Estelle Lorber, MD|
|Palliative Care Expert||Administrative Agent|
|Michael Bouhadana, MD, CM, CCFP||Christine Mazzamauro (514) 340-8222 x 3114|
|Zeev Rosberger, PhD||Ana Massa (514) 340-8222 x 3114|
|Tobi Klein, MSW, MFT, TEP, CGP||Sonia Brin, RN, and the team of the Operating Room|
|Social Worker||Anne Ross BScN, CMSN(C) and the team from 3NW|
|Christina Cabral, MSW, ts, tcf||Cania Vincelli, RN, BSc, MScN, and the team of 5NW|
|Holistic Consultant||Dina Linardos, BScN, CON(c) and the team from the Oncology|
|Susan Wener||Clinic and the Radiation Oncology Clinic|
|Louis-François Coté, PDt||Louise Samuel, BScN, ET|
|Theresa Muccari, PDt||Physiotherapist|
|Hope & Cope Volunteers||Natasha Grant, Pht|
|Cathy Ammendolea||Clinical Research Associates|
|Rita Berger||Iona Eniu|
|Miriam Shuster||Helen Charamis, BScN|
|Hope & Cope Coordinator|
|Hinda Goodman, BSc, MSW|
|Natalie Doan, BPharm|